Equifax Operating Cash Flow decreased by 48.6% to $241.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $223.90M to $241.90M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 4.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $407.70M | $398.40M | $385.30M | -$198.50M | $275.30M | $354.90M | $325.40M | $150.90M | $262.10M | $381.70M | $322.10M | $252.70M | $267.50M | $479.50M | $324.80M | $223.90M | $361.10M | $559.90M | $470.80M | $241.90M |
| QoQ Change | — | -2.3% | -3.3% | -151.5% | +238.7% | +28.9% | -8.3% | -53.6% | +73.7% | +45.6% | -15.6% | -21.5% | +5.9% | +79.3% | -32.3% | -31.1% | +61.3% | +55.1% | -15.9% | -48.6% |
| YoY Change | — | — | — | — | -32.5% | -10.9% | -15.5% | +176.0% | -4.8% | +7.6% | -1.0% | +67.5% | +2.1% | +25.6% | +0.8% | -11.4% | +35.0% | +16.8% | +45.0% | +8.0% |